Model Number 500DM27 |
Device Problem
Central Regurgitation (4068)
|
Patient Problem
Mitral Valve Insufficiency/ Regurgitation (4451)
|
Event Date 04/03/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Medtronic received information that during the implant of this 27mm mitral mechanical valve, it was explanted and replaced with a valve of the same model and size.The reason for the replacement was reported as a moderate leakage was observed after implant near one of the valve leaflets.No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Updated b5 updated d9 updated h6 updated h3 product analysis: the product has been returned and analysis is in progress medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Medtronic received additional information which stated that there were no leaflet restrictions during and after implantation.A transesophageal echocardiogram (toe) revealed a severe leakage due to one intermittent leaflet dysfunction.It was clarified that this dysfunction was not occurring with every heart beat.It was reported that during reoperation, no impingement was observed and rotation of the valve was attempted in the hope that this would resolve the issue.A second toe demonstrated that the issue had not been resolved and the valve was subsequently explanted and replaced.It was mentioned that after explantation, the valve was seen to have more mobility of one of the leaflets at the hinge.It was noted that leaflet motion was tested with the blue actuator during the implant procedure.It was mentioned that the native valve had been excised.It was reported that the physician believed that one of the leaflets had more movement than the other.No additional adverse patient effects were reported.
|
|
Search Alerts/Recalls
|